What's Happening?
Mount Sinai has announced a significant advancement in ophthalmic surgery with the development of miDOC (micro-interventional Dynamic Outflow Curve), a technology designed to provide real-time intraoperative measurements of ocular flow and pressure during
glaucoma surgery. This innovation, led by Dr. Sean Ianchulev and Dr. Gautam Kamthan at the New York Eye and Ear Infirmary of Mount Sinai, aims to address the unpredictability in surgical outcomes for glaucoma patients. Unlike cataract surgery, where outcomes are highly predictable due to advanced optical biometry, glaucoma surgeries have historically lacked real-time data, leading to less successful postoperative results. The miDOC device allows surgeons to dynamically adjust procedures based on immediate physiological responses, potentially transforming the success rates of these surgeries.
Why It's Important?
The introduction of miDOC technology is poised to revolutionize glaucoma surgery by providing surgeons with critical real-time data, thus enhancing surgical precision and outcomes. This development is particularly significant given the high failure rates associated with traditional glaucoma surgeries, where surgeons have had to rely on post-operative assessments to gauge success. By enabling real-time adjustments, miDOC could significantly reduce the risk of postoperative complications and improve patient outcomes. This advancement not only benefits patients by potentially reducing the need for follow-up surgeries but also represents a leap forward in surgical technology, setting a new standard for ophthalmic procedures.
What's Next?
Currently, the miDOC device is investigational and not yet FDA-cleared, but it has been successfully used in the first 20 human cases at Mount Sinai since July 2025. The next steps involve further clinical trials and potential FDA approval. Additionally, researchers are exploring the application of miDOC in cataract surgeries to prevent intraocular pressure spikes post-operation. The technology's ability to detect choroidal blood flow could also provide early warnings for complex chorioretinal diseases, indicating a broad potential for future applications in ophthalmology.
